Search

everythinglearnresearchcommunity

for

Search:↓

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Understanding where cancer cells come from helps create better prevention and treatment methods.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.